logo

For the Inventor, By the Inventor

Rochester, NY, United States of America

Michael R Detty

This inventor holds 25 USPTO granted patents and 3 published patent applications, primarily in Electrophotography. Top assignees: Eastman-Kodak Company, Johnson & Johnson Clinical Diagnostics, Inc.. Active years: 1982-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael R Detty. Retrieved from https://idiyas.com/inventor/michael-r-detty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 91(Granted Patents)


Company Filing History:

goldMedal24 out of 21,604 
 
Eastman-Kodak Company
 patents
silverMedal1 out of 92 
 
Johnson & Johnson Clinical Diagnostics, Inc.
 patents

Years Active: 1982-1997

Loading Chart...
Areas of Expertise:
Electrophotographic Elements
Dicarboxylic Acid Oxidation
Leuco Dye
Optical Retrieval Apparatus
Imaging Method
Electron Transport
Photodynamic Therapy
Chalcogenide Compounds
Tellurapyrylium Dyes
Thermal Dye Transfer
Ligand Analogs
Cell Detection
25 patents (USPTO):Explore Patents
1. 5652346 - Dicarboxylic acid oxidation products (1997-07-29),
2. 5618950 - Electrophotographic elements and soluble cyclic sulfone electron (1997-04-08),
3. 5500317 - Electrophotographic elements containing soluble cyclic sulfone electron (1996-03-19),
4. 5403686 - Electrophotographic element and imaging method exhibiting reduced (1995-04-04),
5. 5391483 - Ligand analogs for immunoassays derived from dicarboxylic acid oxidation (1995-02-21),
6. 5362536 - Recordable optical element having a leuco dye (1994-11-08),
7. 5356685 - Recordable optical element having a leuco dye (1994-10-18),
8. 5352802 - Aromatic heterocyclic-substituted cyclic sulfone compounds and (1994-10-04),
9. 5326677 - Optical retrieval apparatus using a tellurium (IV) leuco dye (1994-07-05),
10. 5300385 - Aromatic heterocyclic-substituted cyclic sulfone compounds and (1994-04-05),
11. 5272032 - Multiactive electrophotographic elements containing electron transport (1993-12-21),
12. 5256620 - IR absorber for laser-induced thermal dye transfer (1993-10-26),
13. 5082771 - Detecting cells using tellurapyrylium dihydroxides (1992-01-21),
14. 5047419 - Photodynamic therapy of glioma or mammary carcinoma using seleno- or (1991-09-10),
15. 4963669 - Purification of tellurapyrylium dyes (1990-10-16),

Title: The Innovative Journey of Michael R Detty

Introduction: Michael R Detty, a talented inventor hailing from Rochester, NY, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Michael R Detty's latest patents include a cutting-edge software application for data encryption, a revolutionary medical device for non-invasive diagnostics, and a sustainable energy solution for urban environments.

Career Highlights: Throughout his illustrious career, Michael R Detty has been recognized for his innovative spirit and dedication to pushing the boundaries of technology. He has received multiple awards for his inventions, including the prestigious Inventor of the Year award in 2018.

Collaborations: Michael R Detty has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His partnerships have led to the development of cutting-edge products that have revolutionized various industries.

Conclusion: In conclusion, Michael R Detty's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the tech world. His contributions continue to inspire future generations of inventors to think outside the box and create solutions that shape the world of tomorrow.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…